ADDvise signs Letter of Intent to acquire Seebreath AB
ADDvise signs Letter of Intent to acquire Seebreath AB ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Seebreath AB (”Seebreath”) regarding an acquisition of 100 percent of the shares in Seebreath. Seebreath is a Swedish medtech company developing and producing colorimetric CO2-indicating products used in respiratory care. The products are mainly used in emergency care to monitor and ensure the safety of intubated patients. The company’s products are FDA approved and sold on the American market through two distributors. Revenue for the financial year